Price T Rowe Associates Inc Inogen Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Inogen Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 25,586 shares of INGN stock, worth $244,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,586
Previous 23,868
7.2%
Holding current value
$244,858
Previous $193,000
8.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding INGN
# of Institutions
135Shares Held
22MCall Options Held
122KPut Options Held
35.4K-
Divisadero Street Capital Management, LP Miami, FL2.35MShares$22.5 Million3.29% of portfolio
-
Camber Capital Management LP Boston, MA2MShares$19.1 Million0.45% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.95MShares$18.7 Million0.33% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$15.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$13.8 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $219M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...